Drug pricing norms: Cost or MRP based?
As the second largest exporter of bulk drugs and largest formulation exporter, the Indian pharmaceutical industry has made its…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Venus Remedies: Reinventing R&D
Generic dominated Indian pharma market also has exceptions like Venus Remedies who wants to make transition from generic to…
Regulatory woes of pharma SMEs (Part I)
Jagmohan Rai Agarwal has experienced the workings of the Indian drug regulatory authorities across the country while engaged in…
Back to the roots Landscaping OTC opportunities in the Indian ayurveda market
Sreedevi Yallamrazu, Senior Strategic Analyst, CubeX comments on the acceptance of traditional medicine for holistic health and…
A holistic view of the HPAPI opportunity
The High Potency Active Pharmaceutical Ingredients (HPAPI) segment is the potential cash cow of the pharma procurement basket but…
Beyond the Ban
The Government of India (GOI) recently banned the use of serology-based test kits for diagnosis of tuberculosis. But this will…
Sanofi ties up with Joslin Diabetes Center
Both parties will have access to intellectual property for internal research use
BoehringerLilly alliance to launch first diabetes drug in India
Boehringer Ingelheim India and Eli Lilly and Company India (Lilly), which represents the Boehringer Ingelheim – Lilly global…
CHMP recommends Novartis drug Afinitor for EU approval
To mark major milestone in the treatment of advanced breast cancer
Daiichi Sankyo and Ranbaxy launch hybrid business in Venezuela
The Venezuelan pharmaceutical market is the third largest in Latin America
COMP adopts recommendations for orphan designation
It also confirmed the orphan designation for Kalydeco
GoI bans use, import of blood test kits for TB
WHO had found that such kits give misleading results and could result in more harm than good
UNITAID approves $30 mn for TB test at reduced cost
The US Government and Bill & Melinda Gates Foundation will reduce the price of diagnostic cartridges from $17 to less than $10…
Public awareness on anorexia improving, but pharma industry still lacking ideas: GlobalData
A new molecule from Daiichi Sankyo, is set to change the scenario when it hits the Japanese market in 2014
DIA India workshop drives IP innovation and collaboration home
Various dimensions of licensing associated with IP protection were discussed among other issues
Pfizer appoints Aijaz Tobaccowalla as Managing Director, India
Previously from Wyeth, Tobaccowalla now leads Business Technology for all Pfizer's biopharma business units
Obamacare passed, but will Obama?
In a landmark judgement, 'Obamacare', President Barack Obama's reform of the US healthcare system, won by a close 5-4 vote in the…
Putting a price to health
Tuberculosis, once known as a poor man’s illness, today shows no class discrimination. Bollywood super stars, top performing super…
New second-line drug for type II diabetes results in less hypoglycaemia: The Lancet
The group treated with linagliptin also experienced fewer cardiovascular events